WX Stock UPDATES Wuxi Pharmatech [Cayman] Inc (WX) 35.17 08/14/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Wuxi Pharmatech [Cayman] Inc (WX) 35.17 $WX

WuXi PharmaTech Announces Second-Quarter 2014 Results
PR Newswire - Wed Aug 13, 3:30PM CDT
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading research and development services company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial results for the second quarter of 2014.

WuXi PharmaTech Announces Appointment of Walter Kwauk to Board
PR Newswire - Fri Aug 08, 7:00AM CDT
WuXi PharmaTech (Cayman) Inc. (NYSE:WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced the appointment of Walter Teh-Ming Kwauk as an independent director to the Board of Directors. Mr. Kwauk will serve on the Audit Committee.

WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release
PR Newswire - Tue Jul 22, 7:00AM CDT
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quarter of 2014 after the New York Stock Exchange closes on Wednesday, August 13, 2014 (which will be Thursday morning, August 14, 2014 Shanghai time). The earnings release will be available on the investor relations section of the Company's website at http://www.wuxiapptec.com .

Scheduled Conference Calls and Managements Changes - Analyst Notes on Spectranetics, Charles River, Chemed, WuXi PharmaTech and Ironwood Pharmaceuticals
PR Newswire - Mon Jul 14, 4:40AM CDT
Today, Analysts Review released its analysts' notes regarding The Spectranetics Corporation (NASDAQ: SPNC), Charles River Laboratories (NYSE: CRL), Chemed Corporation (NYSE: CHE), WuXi PharmaTech (Cayman) Inc. (ADR) (NYSE: WX) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4742-100free.

Director Ying Han Resigns from WuXi Board
PR Newswire - Tue Jul 08, 3:30PM CDT
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that Ying Han has stepped down from the WuXi Board of Directors for personal reasons.

5 Foreign Stocks You Need to Sell This Summer
at The Street - Tue Jul 01, 8:57AM CDT
While overseas markets trail the U.S., lots of individual foreign stocks that trade here in the U.S. are looking downright toxic for your portfolio.

Collaborations, Clinical Study Results, and Laboratory Inspection Clearance - Analyst Notes on Amgen, Regeneron, Lexicon, WuXi PharmaTech and ImmunoGen
PR Newswire - Wed Jun 25, 5:40AM CDT
Today, Analysts Review released its analysts' notes regarding Amgen, Inc. (NASDAQ: AMGN), Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX), WuXi PharmaTech (Cayman) Inc. (NYSE: WX) and ImmunoGen, Inc. (NASDAQ: IMGN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4088-100free.

WuXi AppTec Webinar on Breakthrough Drugs Draws Strong Attendance
PR Newswire - Mon Jun 23, 7:00AM CDT
More than 400 life science innovators recently tuned in to a global webinar hosted by WuXi AppTec to gain insights into the advancement of programs that ultimately have been designated by the U.S. Food and Drug Administration as breakthrough therapies. The breakthrough designation applies to specific drugs that treat serious medical conditions and show signs of substantial improvements over available therapies, and it enables their speedy development and commercialization.

WuXi PharmaTech's toxicology facility passes US FDA's GLP compliance and quality services
M2 - Mon Jun 23, 6:02AM CDT
Pharmaceutical company WuXi PharmaTech (Cayman) (NYSE:WX) disclosed on Friday that its Suzhou toxicology facility has passed the US Food and Drug Administration (FDA) Good Laboratory Practice (GLP) inspection, with no major observations.

WuXi PharmaTech Toxicology Facility in Suzhou Passes FDA Inspection
PR Newswire - Fri Jun 20, 7:00AM CDT
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its toxicology facility in Suzhou recently passed a surveillance Good Laboratory Practice (GLP) inspection by the U.S. Food and Drug Administration (FDA) with no major observations. This was the first FDA GLP inspection in the facility's five years of operation. The inspection was extensive, lasting five days and including the review of numerous processes and the audit of four studies. WuXi's toxicology facility in Suzhou has completed 92 IND-enabling programs for global submissions.

Health Care Sector Stocks Coverage -- Research on RadNet, IMS Health Holdings, WuXi PharmaTech Cayman, and Ventrus Biosciences
PR Newswire - Wed Jun 18, 6:50AM CDT
On Tuesday, June 17, 2014, the NASDAQ Composite ended at 4,337.23, up 0.37%, the Dow Jones Industrial Average finished the day 0.16% higher at 16,808.49, and the S&P 500 closed at 1,941.99, up 0.22%. During the session five out of ten sectors ended in positive. The S&P 500 Health Care Sector Index ended the day at 688.85, down 0.07%, while the index has advanced 2.52% in the last one month. Investor-Edge has initiated coverage on the following equities: RadNet Inc. (NASDAQ: RDNT), IMS Health Holdings Inc. (NYSE: IMS), WuXi PharmaTech Cayman Inc. (NYSE: WX) and Ventrus Biosciences Inc. (NASDAQ: VTUS). Free technical research on RDNT, IMS, WX and VTUS can be downloaded upon signing up at:

Shares of WX Down 10.1% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Jun 16, 10:06AM CDT
SmarTrend identified a Downtrend for WuXi PharmaTech Cayman (NYSE:WX) on April 8th, 2014 at $34.58. In approximately 2 months, WuXi PharmaTech Cayman has returned 10.13% as of today's recent price of $31.08.

Trade-Ideas: WuXi PharmaTech (WX) Is Today's "Dead Cat Bounce" Stock
at The Street - Mon Jun 16, 9:02AM CDT
Trade-Ideas LLC identified WuXi PharmaTech (WX) as a "dead cat bounce" (down big yesterday but up big today) candidate

WuXi PharmaTech (WX) in Focus: Stock Falls 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 16, 7:59AM CDT
Shares of WuXi PharmaTech (WX) fell over 6% on the day. This continues the most recent downtrend for WX, as the stock is down nearly 15% since May 22. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future.

SmarTrend Watching for Potential Rebound in Shares of WuXi PharmaTech Cayman After 6.39% Loss
Comtex SmarTrend(R) - Fri Jun 13, 5:22PM CDT
WuXi PharmaTech Cayman (NYSE:WX) traded in a range yesterday that spanned from a low of $30.41 to a high of $32.76. Yesterday, the shares fell 6.4%, which took the trading range below the 3-day low of $31.11 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Strategic Collaborations, Certified Solutions, Financial Results, Recognitions, and Commencement of Laboratory Operations - Analyst Notes on Quest Diagnostics, Agilent, Nordion, ICON and WuXi PharmaTech
PR Newswire - Thu Jun 05, 4:40AM CDT
Today, Analysts Review released its analysts' notes regarding Quest Diagnostics Inc. (NYSE: DGX), Agilent Technologies Inc. (NYSE: A), Nordion Inc. (NYSE: NDZ), ICON plc (NASDAQ: ICLR) and WuXi PharmaTech (Cayman) Inc. (NYSE: WX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3397-100free.

WuXi PharmaTech Corporate Venture Fund Invests in TruTag Security Platform for Drug Safety
PR Newswire - Tue Apr 01, 7:00AM CDT
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, and TruTag Technologies, Inc., developer of the leading edible, covert security platform to address the global product counterfeiting challenge, today announced that WuXi Corporate Venture Fund has made an investment in TruTag. In addition, WuXi and TruTag will explore collaborations to offer WuXi's global customers the TruTag on-dose authentication solution to help prevent counterfeiting and to enhance drug safety.

Stocks Turn Mixed, Trade Steady; Facebook Drags On Nasdaq
at Investor's Business Daily - Wed Mar 26, 11:04AM CDT
The market weakened into mixed terrain near midday Wednesday, as the Nasdaq dipped a fraction into negative territory. The S&P 500 held its 0.3% gain and the Dow Jones industrial average was ahead 0.2%. Volume remained higher in the stock market...

Endocyte (ECYT) Soars: Stock Adds 94.4% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 7:51AM CDT
Endocyte, Inc. was a big mover last session, as its shares rose over 94% on the day.

IntelliPharmaCeutics International (IPCI) Soars: Stock Rises 9.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 7:51AM CDT
IntelliPharmaCeutics International Inc. was a big mover last session, as its shares rose over 9% on the day.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 211

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 274

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 217

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 162

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
WaterField’s Nova Case Bets on Better Handheld Carry

Updated Category News Views 308

Tiny handhelds have spawned a surprisingly fussy luggage problem: protection without the clown-show aesthetic. WaterField Designs is taking a clean swing at that with a custom case for the Retroid Pocket Nova, a sleeve-like carrier built around the device rather than some generic pouch that leaves everything rattling around inside. This is not a market-moving corporate...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 311

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 210

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 252

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 193

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 411

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
ss="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles